PLK1 and non-small cell lung carcinoma: To our best knowledge, the overexpression of Plk1 observed in several human cancers, such as non-small cell lung cancer (NSCLC) (13, 14) and pancreatic cancer (15), is closely associated with poor prognosis and inferior overall survival (9–11, 16).